Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
GLV8pX4TTx9gA8ju
